Clinical Trial Update: Intravesical Electromotive Mitomycin After Bacillus Calmette-Guérin Failure [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intravesical electromotive delivery of mitomycin after BCG failure in bladder cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Mitomycin (Mitomycin)

Snippet

Sponsor: University of Rome Tor Vergata | Conditions: Bladder Cancer | Phase 2 | Status: COMPLETED